Glipizide
58 NDCs across 14 manufacturers|55 Generic,3 Brand
Glipizide is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 8, 1984, and the first generic was approved May 10, 1994. FDA's Orange Book lists 30 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $91 million on Glipizide across 7.8 million claims for 2.0 million beneficiaries.
Glipizide is available as 58 NDCs from 14 manufacturers (55 generic, 3 brand), with NADAC prices from $0.03 to $1.27 per EA — the most expensive product costs about 37× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
58
55G / 3B
Manufacturers
14
competing in market
Price Spread
$0.03 – $1.27
per EA
7d Activity
avg -2.2% WoW · of 58 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Apotex Corp. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Sulfonylurea class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
14 manufacturers producing GLIPIZIDE(2 pricing outliers)
Frequently Asked Questions
What is Glipizide used to treat?
Glipizide is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
When did Glipizide become available as a generic?
FDA approved the first generic Glipizide (ANDA) on May 10, 1994. The Orange Book currently lists 30 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Glipizide?
In 2024, Medicare Part D spent $91 million on Glipizide across 7.8 million claims for 2.0 million beneficiaries.
How many Glipizide products are on the market?
The Glipizide drug market contains 58 NDCs from 14 manufacturers — 55 generic and 3 brand products.
What is the price range for Glipizide?
NADAC reference prices for Glipizide range from $0.0339 to $1.2674 per EA — the most expensive product costs about 37× the cheapest.
Is generic Glipizide cheaper than brand?
The average generic NADAC for Glipizide is $0.0814 per EA, versus $0.4768 for brand-labeled products — brand versions average about 5.9× the generic price.
Which manufacturers make Glipizide?
14 manufacturers list Glipizide in NADAC. Ranked by number of NDCs, the largest are Apotex Corp. (8), Rising Pharma Holdings Inc. (7), Actavis Pharma, Inc. (6), Oxford Pharmaceuticals, LLC (6), Advagen Pharma Ltd. (6).
How has the price of Glipizide changed recently?
Over the past 7 days, 8 Glipizide NDCs rose and 47 fell, with a market-wide average change of -2.2%.